More stories

  • in

    Merck beats on revenue boosted by Keytruda sales, but posts quarterly loss due to Prometheus deal

    Merck reported second-quarter revenue that topped expectations on strong sales of its blockbuster cancer drug Keytruda and HPV vaccine Gardasil.
    But the pharmaceutical giant posted a quarterly loss due to its acquisition of the biotech company Prometheus Biosciences earlier this year. 
    Merck will hold a conference call with investors at 8 a.m. ET on Tuesday. 

    Merck on Tuesday reported second-quarter revenue that topped expectations on strong sales of its blockbuster cancer drug Keytruda and HPV vaccine Gardasil.
    The pharmaceutical giant posted a quarterly loss, however, due to charges associated with the company’s acquisition of Prometheus Biosciences earlier this year. 

    related investing news

    22 hours ago

    Merck swung to a net loss of $5.98 billion, or $2.35 per share, from a net income of $3.94 billion, or $1.55 per share, during the year-earlier period. Excluding acquisition and restructuring costs, Merck’s loss per share was $2.06 for the quarter. 
    The loss reflects a $10.2 billion, or $4.02 per share, charge related to the company’s acquisition of Prometheus, which specializes in treatments for autoimmune diseases. Merck said it completed the deal in mid-June. 
    Here’s how Merck results compared with Wall Street expectations, based on a survey of analysts by Refinitiv:

    Loss per share: $2.06 adjusted vs. $2.18 expected
    Revenue: $15.04 billion vs. $14.45 billion expected

    Revenue of $15.04 billion for the quarter rose 3% from a year earlier. 
    “What you really see…was long sustained underlying growth, and it was driven by oncology and vaccines, and the Gardasil franchise in vaccines,” Merck CEO Robert Davis said in an interview on CNBC’s “Squawk Box” on Tuesday.

    Merck’s stock rose more than 1% in premarket trading. Shares of Merck are down roughly 4% this year, with a market value of roughly $270 billion, making it the third largest pharmaceutical company based in the U.S.

    Medicine pill is seen with Merck logo displayed on a screen in the background in this illustration photo taken in Poland on October 4, 2021.
    NurPhoto | NurPhoto | Getty Images

    The New Jersey-based company raised its 2023 sales forecast to a range of $58.6 billion to $59.6 billion, slightly higher than the $57.7 billion to $58.9 billion guidance provided in late April. 
    Merck lowered its full-year adjusted earnings outlook to $2.95 to $3.05 per share, from a previous forecast of $6.88 to $7 per share.
    The company said its business growth during the quarter contributed 24 cents per share to the full-year earnings guidance, but was offset by the $4.02 per share charge related to the Prometheus deal.
    The outlook also includes previously disclosed one-time charges related to Merck’s acquisition of Imago BioSciences last year and an upfront payment for a drug development agreement with Kelun-Biotech. 
    “We see strong growth to the full year, and the guidance range you are referencing implies growth of 10% to 11% if you exclude the one-time impact,” Davis told CNBC. “It’s a strong beat.”

    Strong pharmaceutical sales 

    Merck’s pharmaceutical business, which develops a wide range of drugs for different disease areas, booked $13.46 billion in revenue during the quarter. That’s up 6% from the same period a year ago. 
    Excluding Merck’s Covid antiviral treatment molnupiravir, the pharmaceutical division revenue grew 14%. 
    Sales of molnupiravir, sold under the brand name Lagevrio, plunged to $203 million during the period, down 83% from the $1.18 billion reported for the second quarter of 2022. Analysts had been expecting the drug to rake in $187.6 million in sales, according to FactSet estimates.
    The decline isn’t a surprise. Sales of molnupiravir and other Covid products from companies like Pfizer have plummeted this year as the world emerges from the pandemic and relies less on vaccines and treatments for protection. 
    The pharmaceutical division’s growth was largely fueled by the popular antibody treatment Keytruda, which is used to treat several types of cancer.
    The drug booked $6.27 billion in revenue, up 19% from the year-earlier quarter. Analysts had been expecting $5.97 billion in Keytruda sales, FactSet estimates said.
    Davis said “that’s the first time we have been over $6 billion and a quarter” for Keytruda sales.
    The company has been under pressure to reduce its dependence on Keytruda, which is slated to lose patent protection in 2028. But Merck is trying to defend its patent edge over Keytruda by developing new formulations of the drug, such as a version that can be injected under the skin.

    Merck & Co. Keytruda cancer treatment drug.
    Source: Merck & Co.

    Merck’s pharmaceutical business also saw a jump in sales of Gardasil, a vaccine that prevents cancer from HPV, the most common sexually transmitted infection in the U.S.
    Gardasil raked in $2.46 billion in sales, up 47% from the second quarter of 2022. Analysts had been expecting sales of $2.10 billion, according to FactSet estimates.
    The company’s animal health division, which develops vaccines and medicines for dogs, cats and cattle, posted $1.46 billion in sales, off 1% from the same period a year ago.
    Merck will hold a conference call at 8 a.m. ET on Tuesday. 
    Investors are eager for updates on upcoming product launches and other drug pipeline updates that could cushion Keytruda’s patent cliff if they gain approval.
    That includes Merck and Moderna’s experimental personalized cancer vaccine, which is being studied in combination with Ketyruda. The drugmakers launched a phase three trial of the vaccine last week. 
    Other products include Merck’s experimental vaccine that aims to prevent invasive pneumococcal disease and pneumococcal pneumonia in adults. More

  • in

    Walmart is bringing ads to an aisle near you as retailers chase new money-makers

    Walmart is pushing into in-store advertising to capitalize on its huge reach and chase growth in higher-margin businesses.
    Walmart shoppers will soon see more third-party ads on screens in self-checkout lanes and TV aisles; hear spots over the store’s radio; and be able to sample items at demo stations.
    Retailers have a unique opportunity to offer targeted ads, but have to be careful not to irritate or overwhelm shoppers.

    Walmart is turning more parts of its stores into advertising opportunities. For example, brands can buy a spot on its self-checkout screens.

    One of Walmart’s latest offerings at its SuperCenters isn’t a hot new toy, snack flavor or sundress. It’s advertising.
    Shoppers will soon see more third-party ads on screens in Walmart self-checkout lanes and TV aisles; hear spots over the store’s radio; and be able to sample items at demo stations.

    related investing news

    Walmart’s push into advertising resembles similar moves by retailers like Kroger, which struck a deal to bring digital smart screens to cooler aisles in hundreds of its stores, and Target, which began testing in-store demos and giveaways, including a recent “Barbie” branded event with Mattel that took place at about 200 stores.
    For Walmart, selling ad space to its wealth of existing partners is another way to capitalize on the company’s huge reach and to expand into higher-margin businesses. The discounter has nearly 4,700 stores across the U.S., with roughly 90% of Americans living within 10 miles of a Walmart store.
    In the U.S., about 139 million customers visit Walmart stores and its website or app each week.
    “When you think about our store, our store footprint and the the percentage of Americans that we reach through our stores, we can deliver Super Bowl-sized audiences every week,” said Ryan Mayward, senior vice president of retail media sales for Walmart Connect, the retailer’s advertising business.
    The company plans to ramp up in-store ads using its approximately 170,000 digital screens across its locations as well as 30-second radio spots that will be available to suppliers later this year and can target a specific store or region.

    And it’s hoping at least one of the new advertising initiatives will be easy to digest: Free samples in stores on the weekends.
    Walmart plans to sell the sampling stations to advertisers and bundle them with other ad formats that can run at the same time to make for a fuller campaign. QR codes at the demo tables will pull up online shopping options, meal ideas or seasonal information.
    It tried out the new in-house approach of selling sampling stations in Dallas-Fort Worth and plans to offer the option in over 1,000 stores across the country by end of January.
    Advertising still drives a small sliver of Walmart’s overall revenue. Its global advertising business hit $2.7 billion in the most recent fiscal year, which ended in late January. That’s less than 1% of Walmart’s total annual revenue.
    Yet it is becoming a more meaningful growth engine for Walmart. CEO Doug McMillon said earlier this year that he expects company profits to grow faster than sales over the next five years, driven in part by higher-margin businesses, including advertising.
    In the most recent fiscal year, Walmart’s global ads business grew nearly 30% and its U.S. ads business, Walmart Connect, rose about 40%. That’s a sharper gain than the approximately 7% increase in Walmart’s total revenue and Walmart U.S. net sales during the period.

    The next frontier

    As Walmart and other retailers grow their ad businesses, the store stands as the next frontier. Target, Kroger and others have pushed aggressively into retail media, a buzzy term used to describe marketing to shoppers based on customer data.
    That side hustle has become a more substantial revenue stream for retailers, especially as brands look for new ways to reach big audiences. Retail media is on track to be a $45 billion industry this year, up 20% from the prior year, according to Insider Intelligence. The market researcher expects that growth to accelerate in the coming years and reach about $106 billion in 2027.
    Yet up until recently, retailers, including Walmart, have largely focused on selling online ads and steered clear of adding digital signs or flashier ads to the places that draw higher traffic and drive the vast majority of sales: Their own stores.
    Walmart’s Mayward said the retailer has added advertising to stores “in a very deliberate and cautious way” after learning how shoppers respond to online ads.
    When done right, he said ads can enhance the experience for shoppers and lift sales. For example, he said, a customer may spring for a sound bar after learning about the product on the TV wall when walking through the electronics department. They may decide to buy a jar of salsa after seeing a video of it near the aisle of their favorite bag of chips.
    “It’s a complimentary advertising moment,” he said. “It’s helping you make connections between two different products and decide that you maybe need that second thing.”

    Walmart is turning the approximately 170,000 digital screens across its U.S. stores into advertising opportunities. For example, a company that makes a snack or a beauty product can advertise in the TV aisle of the electronics department.

    According to Mark Boidman, head of media at New York City-based investment bank Solomon Partners, that proximity offers a unique opportunity that online advertising can’t replicate.
    “It’s better to reach people with video when you’re aisles apart as opposed to miles apart,” Boidman said.
    He noted it’s gotten harder for brands to get in front of large audiences as customers increasingly fracture into smaller groups that watch different TV shows, subscribe to different streaming services or tune in to different broadcast channels.
    Plus, he added, they want to more closely track if marketing dollars lead to sales. Grocers and big-box retailers have valuable first-party data that can better measure that, since they can advertise a product and then use a loyalty program or sales patterns to see if it became more popular.
    But that additional data can be a double-edged sword. He said companies must respect shoppers’ privacy concerns, too. If an advertisement is too targeted to an individual, they may feel creeped out.

    The right balance

    With the debut of more in-store ads, retailers risk those privacy concerns as well as backlash from shoppers who may see the ads as unsightly or irritating.
    That’s already played out at Walgreens: The drugstore added digital smart screens that flashed ads on fridge doors in many of its U.S. stores. Some shoppers complained on TikTok and Twitter that the doors made it hard to find ice cream, pizza or other frozen and chilled items they wanted.
    Walgreens CEO Roz Brewer, who stepped into her role after the deal got signed, didn’t like them either, according to a lawsuit filed last month by Cooler Screens, the company behind the tech. It alleges Walgreens was in breach of contract after breaking off an installation agreement.
    The drugstore chain had agreed to install the screens in at least 2,500 stores across the U.S., according to the lawsuit, but Brewer squashed the rollout after visiting the stores and comparing the screens “to ‘Vegas’ in a derogatory way.”
    Walgreens disputed Cooler Screens’ claims and said it terminated its contract with the firm based on its “failure to perform.”

    Cooler Screens has converted stores’ frozen and refrigerated aisles into places where companies can advertise.
    Cooler Screens

    In an interview with CNBC, Cooler Screens co-founder and CEO Arsen Avakian acknowledged that bringing ads into physical stores is tricky. But he said stores need a more modern look that allows shoppers to search, sort and discover merchandise like they do online and in apps.
    Kroger plans to install Cooler Screens in 100 stores by end of year and reach 500 by next year. Walmart piloted Cooler Screens technology, but ultimately decided not to expand it.
    Andrew Lipsman, a retail and e-commerce analyst for Insider Intelligence, said retailers have to tread lightly to avoid creating the real-world equivalent of pop-up ads.
    “There’s a concern of it looking too much like Times Square,” said Lipsman, who previously worked for Cooler Screens and has closely followed retail media.
    As retailers expand ads into stores, they can start with lower-risk spots like pharmacy or deli counters where customers may welcome a distraction as they wait, he said, adding that stores have plenty of subtle ads already. Brands pay for prominent spots at the end of aisles or for signs that spread the word about a seasonal snack, discount or new product.
    And people have gotten used to seeing digital ads in other parts of the physical world, such as around the perimeter of major sports arenas.
    “There’s digital signage everywhere,” Lipsman said. “It’s become pervasive across many contexts. It’s natural it’s going to enter the store.”
    Disclosure: CNBC’s parent company, NBCUniversal, is a media partner of Walmart Connect. More

  • in

    JetBlue cuts forecast on shift to international travel, end of American Airlines partnership

    JetBlue Airways slashed its 2023 outlook and warned of a potential loss in the current quarter.
    JetBlue forecast annual earnings per share of no more than 40 cents, down as much as $1.
    The airline said it is challenged by a shift toward international travel.

    A Jet Blue aircraft takes off from Long Beach Airport in Long Beach, CA.
    Tim Rue | Bloomberg | Getty Images

    JetBlue Airways slashed its 2023 outlook and warned of a potential loss in the current quarter as travelers opt for destinations abroad and the carrier grapples with the end of its partnership with American Airlines in the Northeast.
    JetBlue forecast adjusted earnings per share for the full year ranging from 5 cents to 40 cents, down from an earlier estimate for per-share earnings of as much as $1.

    related investing news

    The New York-based carrier said it could post an adjusted loss of as much as 20 cents in the third quarter with revenue down 4% to 8% from the same period last year.
    The airline’s shares were down close to 5% in premarket trading after reporting second-quarter results.
    Here’s how the company performed in the period, compared with Wall Street expectations, according to Refinitiv consensus estimates:

    Adjusted earnings per share: 45 cents vs. 44 cents expected
    Revenue: $2.61 billion vs. $2.61 billion expected

    JetBlue reported net income of $138 million for the second quarter, or 41 cents a share, up from a net loss of $188 million, or 58 cents a share, a year earlier. Revenue rose 6.7% to $2.61 billion, roughly in line with analyst estimates.
    Airline executives this earnings season have noted a shift in demand toward long-haul international travel, which was hurt during the pandemic.

    That change along with increased capacity is driving down domestic airfare, as travelers opt for new destinations abroad, they said on recent earnings calls.
    JetBlue’s COO Joanna Geraghty said the shift is “pressuring demand for domestic travel during the peak summer travel period.
    “While we remain on track to deliver a profitable year and record revenue performance, we are taking action, including redeploying capacity to mitigate these current challenges and improve margins,” she said in an earnings release.
    Other challenges include the end of JetBlue’s alliance with American Airlines in New York-area airports and Boston after a judge ruled it anticompetitive and ordered them to scrap it. The partnership allowed the carriers to share passengers and revenue and coordinate routes. The two airlines stopped selling each other’s flights late last month.
    Geraghty also cited air traffic constraints in the Northeast. Both JetBlue and United Airlines said a shortage of air traffic controllers exacerbated flight disruptions resulting from thunderstorms in late June and July.
    About 46% of JetBlue’s flights arrived late from July 1 through July 30, according to FlightAware, with an average delay time of 85 minutes, higher than the national average of 28% of flights delayed for an average of 60 minutes. More

  • in

    Planet lays off about 10% of workforce as satellite imagery company restructures

    Satellite-imagery and data-analysis company Planet is restructuring and laying off 117 employees.
    “This action was taken to increase the company’s focus on its high priority growth opportunities and operational efficiency, which the company believes will further support its long term strategy and path to profitability,” Planet wrote in a securities filing.
    Planet CEO Will Marshall, in a company-wide note, wrote that “I want to be clear that I am responsible for the decisions that led us here.”

    Traders work on the floor of the New York Stock Exchange (NYSE) on December 08, 2021 in New York City.
    Spencer Platt | Getty Images

    Satellite-imagery and data-analysis company Planet is restructuring and laying off 117 employees, it announced on Tuesday.
    The layoffs affect about 10% of Planet’s approximately 1,000 employees.

    “This action was taken to increase the company’s focus on its high priority growth opportunities and operational efficiency, which the company believes will further support its long term strategy and path to profitability,” Planet wrote in a securities filing.
    Planet CEO Will Marshall, in a company-wide note on Tuesday morning, wrote that “I want to be clear that I am responsible for the decisions that led us here.”
    “I know this has significant effects on the lives of our team and their families, and for that I am sorry. We do not make these changes lightly,” Marshall added.

    Sign up here to receive weekly editions of CNBC’s Investing in Space newsletter.

    Planet’s stock was little changed in premarket trading from its previous close of $3.75 a share. The stock is down about 15% year-to-date.
    Earlier this year, the company lowered its annual forecast, citing a “challenging macro environment.”

    Marshall noted that Planet’s expansion since the company went public in December 2021 “increased cost and complexity, which slowed us down in some regards.”
    “We are making changes to prioritize our attention on the highest ROI opportunities for our business and mission, while reinforcing our path to profitability, consistent with what we shared on our prior earnings call,” Marshall added. More

  • in

    ‘Barbenheimer’ is a billion-dollar win for the global box office

    Combined, “Barbie” and “Oppenheimer” have grossed more than $1 billion globally.
    The two movies also showed extraordinary staying power in the second weekend at the domestic box office.
    “Barbie” could end up grossing more than $1 billion by itself, when all is said and done.

    Movie posters for Barbie and Oppenheimer are pictured outside of the Cinemark Somerdale 16 and XD in Somerdale, New Jersey, 2023.
    Hannah Beier | The Washington Post | Getty Images

    “Barbenheimer” remains red-hot at the box office.
    The combined force of Warner Bros.’ “Barbie” and Universal’s “Oppenheimer” has led to more than $1.1 billion in global ticket sales since July 21.

    related investing news

    11 hours ago

    Domestically, “Barbenheimer” saw smaller-than-average second week ticket sales drops as millions of moviegoers headed to cinemas to catch the popular flicks. In fact, both films’ ticket sales fell just 43% from their opening weekends.
    Typically, blockbuster features will see ticket sales fall between 50% and 70% after the debut weekend. Second week numbers are often looked at by box office analysts as an indicator of whether a film will have longevity at the box office or will fizzle quickly. The smaller the drop, the better.
    “‘Barbenheimer’ will go down as one of the most notable and unforeseeable milestones in the history of cinema not just for what it means to the bottom-line box office dollars for the industry but also as a cultural event centered around moviegoing,” said Paul Dergarabedian, senior media analyst at Comscore.
    Over the weekend, “Barbie” added $93 million, bringing its domestic haul to $351 million. The Greta Gerwig and Mattel collaboration for Warner Bros. is nearing $800 million worldwide and could become the second billion-dollar film of 2023.
    Universal’s “Oppenheimer,” meanwhile, tallied another $46.7 million over the weekend. Its domestic gross now stands at $175 million. Globally, it’s generated $405 million.

    “For a domestic summer marketplace desperately in need of a box office boost, the July 21 simultaneous theatrical debuts of ‘Barbie’ and ‘Oppenheimer’ set off a chain reaction of overall box office that has infused the all-important season with nearly three quarters of a billion dollars of bonus cash,” Dergarabedian said.
    Heading into “Barbenheimer’s” first weekend, the summer box office, which runs from the first weekend in May through Labor Day, was down around 7% compared to 2022. Two weeks later, it’s up 9%, according to data from Comscore.
    Similarly, the confluence of these two films boosted the overall domestic box office compared with last year’s haul to this point. Prior to “Barbenheimer,” ticket sales were up 12%. Two weeks later, they were up 20%.
    The overall domestic box office still lags behind prepandemic levels by around 16%, however. And prospects for catching up are dwindling as studios have started to move big releases to next year as Hollywood digs in for drawn-out writers’ and actors’ strikes.
    Disclosure: Comcast is the parent company of NBCUniversal and CNBC. NBCUniversal is the distributor of “Oppenheimer.” More

  • in

    What if Germany stopped making cars?

    “THE FUTURE of the VW brand is at stake.” When Thomas Schäfer, the mass-market marque’s newish boss, gave a presentation to his management team in early July, he did not sugarcoat its problems. High costs, falling demand, growing competition—the list goes on. “The roof is on fire,” he warned, echoing one of the most noted alarm calls in recent business history—from Stephen Elop, who in 2011 compared his company to a “burning platform” shortly after taking the helm at Nokia, then the world’s largest maker of mobile phones.In the case of Nokia, the wake-up call did not help. A few years later the firm was dismantled and its mobile-phone business sold to Microsoft, which has since closed it down. Could mighty VW, its mightier parent group, which owns nine other brands, or even Germany’s mightiest industry as a whole really suffer a similar fate? And if it did, what would that mean for Europe’s biggest economy? An imminent implosion of the car industry seems unlikely. In 2022 Volkswagen was the world’s largest carmaker by revenue, giving it plenty of cash to support its biggest brand. On July 27th it reported that sales rose by a healthy 18% in the first half of 2023, year on year, to €156bn ($174bn). BMW and Mercedes-Benz, Germany’s two other big automotive concerns, are in decent nick. Yet disaster is no longer inconceivable. German industrialists are feeling real angst about the future. In July an index of business confidence from Ifo Institute, a think-tank, fell for the third consecutive month. German bosses echo Mr Schäfer’s list of concerns and add other gripes, from bunged-up bureaucracy to the delicate geopolitics of trade with China. Carmakers are more exposed to these challenges than most industries, as they are having to negotiate several transformations at once. They must electrify their fleet, for instance, and learn to develop software. As these trends play out, more of the value added is likely to come from elsewhere. Industry insiders admit that factories will have to shrink or even close down, as will many suppliers, especially those which make parts for internal combustion engines and gearboxes. Germany’s car industry must also tackle its growing China problem. Having benefited from the Asian giant’s rapid growth in recent decades—in the second half of 2022 Germany’s three big car companies made around 40% of their revenue there—they are now suffering from a reversal of fortunes. Volkswagen has just cut its global delivery forecast owing chiefly to slowing Chinese sales. Geopolitics are liable to make things worse. And Chinese rivals have started expanding abroad, particularly in Europe. Last year, for the first time, China exported more cars than Germany: around 3m and 2.6m vehicles, respectively.Driven to extinction?All these problems are coming together in Wolfsburg, home to Volkswagen’s headquarters—and thus the roof in Mr Schäfer’s metaphor. According to press reports, orders for the group’s EVs are between 30% and 70% below plans, depending on the marque. The firm still has to sort out its software problems: in May it again shook up the management team of Cariad, its digital unit. In China’s fast-growing market for EVs, the VW brand is an also-ran, with a market share of 2%. The consequences of carmakers’ potential demise depend on how big you think the industry is. Carmaking directly employs fewer than 900,000 people in Germany, two-thirds of them at the car firms and the rest at their suppliers. That is just 2% or so of Germany’s total workforce. Nearly three-quarters of passenger cars sold under a German brand are now made abroad. Last year a mere 3.5m vehicles left local factories—about as many as in the mid-1970s.Worried industry insiders point to alternative measures. More than half of the EU’s carmaking gross value added is produced in Germany, miles ahead of France, which is second with 9%. Cars account for 16% of German exports of goods. And although the economic importance of Germany’s car industry peaked at 4.7% of the country’s gross value added in 2017, the share was still at 3.8% in 2020, the last year for which data are available, calculates Nils Jannsen of the Kiel Institute, a think-tank. According to other estimates, this is about a percentage point more than other carmaking powerhouses such as Japan and South Korea.Moreover, zeroing in on narrow industry numbers misses the sector’s true importance for Deutschland AG. “It’s an operating system of sorts,” explains Oliver Falck, who runs the Ifo Centre for Industrial Organisation and New Technologies. “Important parts of the German economy and its institutions rely on it,” he says.For starters, direct suppliers are not the only ones to depend on Volkswagen and its peers. More recent numbers are hard to come by, but according to a study in 2020 by Thomas Puls of IW, another think-tank, and others, global demand for German cars accounted for more than 16% of the value added of Germany’s metal bashers and plastics makers. They also estimated that such global demand indirectly paid for another 1.6m jobs, bringing the total number of people supported by the car industry to 2.5m, more than 5% of the German workforce. German investment and innovation are tied to the country’s carmakers. The car industry accounted for 35% of gross fixed capital formation in manufacturing in 2020, according to IW. In 2021 the sector was the source of more than 42% of manufacturing research and development and paid for 64% of all R&D conducted by other firms and research institutions, based on numbers from the Stifterverband, an association mostly of research foundations. According to IW, carmakers accounted for nearly half of corporate patent filings in 2017, up from a third in 2005.The car industry is also central to Germany’s much-vaunted social model. One important element is regional equality. Car factories were often built in otherwise economically weak areas, of which Wolfsburg is the prime example. The sector shores up many of these regions. According to one recent study, 48 of Germany’s 400 cities and counties are heavily dependent on jobs in the car industry. Wolfsburg leads the pack: 47% of the city’s workers toil in the sector. Should carmaking fade, Germany would face “many local crises”, says Wolfgang Schroeder, one of the authors of the study and a fellow at the WZB, a research outfit.Without a strong car industry, Germany’s generally placid industrial relations would become much rougher. Union leaders such as Roman Zitzelsberger, who heads IG Metall in Baden-Württemberg, the state that is home to Mercedes-Benz, Porsche and Bosch, a giant car-parts supplier, freely admit that it is the organisation’s “backbone”. IG Metall’s some 2m members make it the world’s single biggest trade union. About a third of them work in the car industry. Union membership at some companies in the sector reaches 90%. This strength, in turn, helps IG Metall negotiate good wage deals which then radiate out to other firms and industries where it is less entrenched.The car industry also undergirds Germany’s model of co-determination, where workers are guaranteed representation on corporate boards. Volkswagen is again the prime example. The sector’s powerful works councils provide IG Metall with access to important resources, from money to information. Employee representatives make up half the firm’s 20-member supervisory board, giving them access to regular updates about the company’s condition and the ability to veto strategic decisions. (Another two members are political appointees from the state of Lower Saxony, which owns 12% of the group.)If this arrangement were to fall apart, it would alter the balance of Germany’s labour market, reckons Sebastian Dullien, an economist at the Hans-Böckler-Stiftung, a trade-union think-tank. “To exaggerate only a bit, it will make a big difference whether Volkswagen manages its transformation or whether it is replaced by Tesla,” he says, referring to the American EV pioneer, which has just announced that it intends to expand its plant near Berlin to what will be Europe’s biggest car factory. Over time, says Mr Dullien, manufacturing jobs in Germany would no longer be exceptionally well paid relative to service ones and manufacturing jobs in other European countries.Harder to measure, but no less profound, would be the psychological effects of a diminished German car industry. The reputation of German industry and its engineering prowess, already knocked by Volkswagen’s “Dieselgate” emissions-cheating scandal of 2015, would take another hit. In a paper published last year, Rüdiger Bachmann of the University of Notre Dame and others calculated that because the company was found fiddling with emissions readings, sales of other German brands in America fell by 166,000 cars, costing them $7.7bn in forgone revenues, or nearly a quarter of their total in 2014. If Germany’s car industry were to evaporate, in other words, this would “leave a huge economic crater in the midst of Europe”, says Mr Schroeder of WZB. Germany’s politicians are, of course, desperate not to let that happen. After Dieselgate, their support for the sector is less wholehearted. But subsidies such as tax breaks for company cars, which make it worthwhile for employees to forgo a part of their salary in exchange for a high-end vehicle, are not going away. More than two in three new cars in Germany are bought by companies; many end up being driven mostly on personal trips.In Lower Saxony the car industry may well be too big to let fail. Volkswagen operates factories in five places besides Wolfsburg. Altogether, the firm employs about 130,000 people there. The state’s politicians need only look next-door at Thuringia to see what might happen if its economy floundered—which it inevitably would were Volkswagen to crumble. The far-right Alternative for Germany party now leads Thuringian polls with 34%.Riding into the sunsetSuch considerations are drowning out voices pointing out that extending life support for carmakers could be counterproductive in the long term. Mr Bachmann thinks German politicians need to put a bit more faith in market forces to fill the economic space that might open up as German carmaking wanes. Germany’s oversized car industry, once a strength, increasingly holds the country back, argues Christoph Bornschein of TLGG, a consultancy. “Cars are the biggest manifestation of Germany’s total focus on mechanical engineering,” he says. As Volkswagen’s ongoing problems with its software unit show, an economic system that is optimised to churn out expensive mechanical wonders that run like clockwork will struggle to reinvent itself in an increasingly digitised world.Once the car industry is no longer that dominant, there would be more space for alternatives. Fewer subsidies would flow into the sector, and more capital into startups. Fewer young Germans would study mechanical engineering and more opt for computer science instead. And researchers would put more effort into, say, developing mobility services instead of filing one more car-related patent.The freewheeling approach has worked for Eindhoven. The Dutch city, once as dominated by Philips, a one-time electronics giant, as Wolfsburg is by Volkswagen, now hosts thousands of small companies. Most of these supply ASML, a manufacturer of advanced chipmaking equipment that has emerged as one of Europe’s most valuable companies. Espoo, still home to the rump Nokia, which today makes telecoms networking gear, also now boasts a thriving startup ecosystem. Admittedly, carmaking is much more deeply rooted than the ephemeral production of electronics such as mobile phones. As such, especially if the decline is gradual, the sector will adapt. Big suppliers such as Bosch or Continental will work more for foreign carmakers such as Tesla (in the Californian firm’s early days, Bosch is said to have provided 80% of its value added). Smaller suppliers will specialise and provide services, as many Mittelstand firms have done before. And Germany is likely to stop producing cheaper cars and focusing even more on making smaller numbers of higher-margin luxury ones. Volkswagen may even turn itself into a contract manufacturer, assembling EVs for other brands, much as Foxconn puts together iPhones for Apple.Some in and around the industry are already imagining a future without Volkswagen, at least as it exists today. The business “needs to stop building its strategies only around the car”, says Andreas Boes of ISF Munich, another research outfit. Mr Boes leads a group of youngish car-industry executives and experts which recently published a “Mobilistic Manifesto”. Instead of making cars ever more comfortable, so people spend more time in them and can be sold additional services, firms should aim to organise society’s ability to go from A to B as a whole, he suggests. Volkswagen and its fellow German carmakers have always helped people move around. There is no reason why they shouldn’t keep doing it in clever new ways. ■ More

  • in

    Cannabis companies Cresco, Columbia Care call off $2 billion merger as industry awaits banking reform

    A $2 billion mega-deal between cannabis multistate operators Cresco Labs and Columbia Care has gone up in smoke more than a year after the companies announced the acquisition.
    The termination was agreed upon mutually, the companies added, and neither party will pay any related penalties or fees.
    The termination comes as the cannabis industry struggles to scale as it awaits crucial federal and banking reform.

    A worker trims leaves of young cannabis plants in a greenhouse at a Cresco Labs Inc. facility in Indiantown, Florida, U.S., on Monday, March 28, 2022.
    Eva Marie Uzcategui | Bloomberg | Getty Images

    A $2 billion mega-deal between cannabis multistate operators Cresco Labs and Columbia Care has gone up in smoke more than a year after the companies announced the acquisition, the companies said Monday.
    The merger, announced in March 2022, would have created the largest cannabis company in the U.S. and been a boon for an industry showing signs of slowdown as it weathers economic and regulatory challenges.

    related investing news

    8 hours ago

    “In light of the evolving landscape in the cannabis industry, we believe the decision to terminate the planned transaction is in the long-term interest of Cresco Labs and our shareholders,” Cresco CEO Charles Bachtell said in a statement.
    The termination was agreed upon mutually, the companies added, and neither party will pay any related penalties or fees.
    The plan for Chicago-based Cresco to buy New York-headquartered Columbia Care in an all-stock transaction began to unravel when the companies failed to divest enough assets necessary for regulatory approvals by a June 30 deadline.
    Bachtell said in the press release this is a “tough economic time” for the industry and that Cresco will double down on its core business, including “swift restructuring of low-margin operations.”
    Cresco’s market capitalization is about $700 million, down from about $2.7 billion when the deal was announced. Columbia Care has a market cap of about $200 million.

    Columbia Care CEO and co-founder Nicholas Vita added that after careful consideration, the decision to remain solo is “the best path forward for Columbia Care’s employees, customers, and shareholders.”
    The companies also said Monday they’ve scrapped a $185 million deal with Sean “Diddy” Combs that would see the hip-hop mogul acquire some divested operations in New York, Massachusetts and Illinois.

    The cannabis landscape has been in downturn recently, as sales decline in many legal states and investment money dries up. The industry isn’t seen as the safe bet it once was amid a lack of federal regulation and banking reform that has kept operators from scaling.
    The Secure and Fair Enforcement Banking Act, or SAFE, is the most crucial of such reforms needed to grow the cannabis industry. The bipartisan legislation would free up banking services for the cannabis industry, which has been kept out of traditional banking and loans due to marijuana’s federal standing as a Schedule I substance, along with heroin and LSD. 
    Last year, the legislation failed to advance through Congress for the seventh time, despite the industry’s best efforts to galvanize lawmakers behind it. Senate Majority Leader Chuck Schumer (D-NY), who’s leading the push for SAFE banking in Congress, has signaled it may pass this fall. More

  • in

    NIH to test Pfizer’s Paxlovid, other treatments as potential long Covid therapies

    The U.S. National Institutes of Health said it launched mid-stage clinical trials to test at least four treatments, including Pfizer’s antiviral Covid-19 pill Paxlovid, as potential therapies for long Covid. 
    There is no proven treatment for the condition, which affects an estimated 23 million Americans.
    NIH will test the safety and effectiveness of the treatments – which include both drugs and medical devices.

    Paxlovid, Pfizer’s anti-viral medication to treat the coronavirus disease (COVID-19), is displayed in this picture illustration taken October 7, 2022.
    Wolfgang Rattay | Reuters

    The National Institutes of Health said Monday it launched mid-stage clinical trials to test at least four treatments, including Pfizer’s antiviral Covid-19 pill Paxlovid, as potential therapies for long Covid. 
    There is no proven treatment for the condition, which refers to symptoms that continue or develop in the weeks or months following an initial Covid infection. It affects an estimated 23 million Americans.

    related investing news

    11 hours ago

    Health-care providers typically try to treat the often debilitating symptoms associated with long Covid, such as chronic pain, memory loss and intense fatigue. But the lack of a specific long Covid treatment pushes some patients to seek unproven – and potentially dangerous – remedies for the condition. 
    “We know that when patients are suffering, we can never move fast enough,” said acting NIH Director Dr. Lawrence Tabak. “NIH is committed to a highly coordinated and scientifically rigorous approach to find treatments that will provide relief for the millions of people living with long COVID.”
    The NIH will test the safety and effectiveness of the treatments – which include both drugs and medical devices – in groups of 100 to 300 patients with long Covid symptoms. 
    The first part of the phase two trial will test a longer dosing regimen of Paxlovid to see if it improves long Covid symptoms. 

    CNBC Health & Science

    Read CNBC’s latest health coverage:

    Patients typically take Paxlovid within five days of developing Covid symptoms to reduce their risk of hospitalization or death, according to the Food and Drug Administration’s approval of the drug in May. To complete a full course of Paxlovid, patients must take three pills twice a day for five days. 

    The NIH said another part of the study will also test for brain fog and memory-related symptoms.
    The agency will test medical treatments like a web-based brain training program called BrainHQ and a device that uses a small electric current to stimulate brain activity. 
    The NIH expects to launch additional clinical trials to test at least seven more treatments “in the coming months.”  More